Last $5.20 USD
Change Today -0.05 / -0.95%
Volume 200.0K
NEO On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Douglas M. VanOort

Executive Chairman and Chief Executive Officer, Neogenomics Inc.
AgeTotal Calculated CompensationThis person is connected to 5 board members in 2 different organizations across 6 different industries.

See Board Relationships
59$719,773
As of Fiscal Year 2013

Background*

Mr. Douglas M. VanOort, also known as Doug, has been the Executive Chairman and Chief Executive Officer of Neogenomics Inc. since October 28, 2009. Mr. VanOort joined Neogenomics on March 16, 2009. Mr. VanOort serves as an Operating Partner at Summer Street Capital Partners L.L.C. He joined Neogenomics on November 1, 2004. He serves as Managing Director of Conundrum Capital Partners. He gained his business strategy, operations, finance, and organizational development ...

Read Full Background

Corporate Headquarters*

12701 Common Wealth Drive
Fort Myers, Florida 33913

United States

Phone: 239-768-0600
Fax: 239-690-4237

Board Members Memberships*

Former Director
Former Chief Executive Officer, President and Director
2009-Present
Executive Chairman and Chief Executive Officer
2009-Present
Executive Chairman and Chief Executive Officer

Education*

Unknown/Other Education
Bentley University

Other Affiliations*

Annual Compensation*

Salary$425,000
Bonus$132,000
Total Annual Compensation$557,000

Stock Options*

Exercisable Options1,200,000
Unexercisable Options600,000
Total Number of Options1,800,000

Total Compensation*

Total Annual Cash Compensation$564,429
Total Short Term Compensation$557,000
Total Calculated Compensation$719,773
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEO:US $5.20 USD -0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
--
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Panna Sharma Chief Executive Officer, President and Director
Cancer Genetics, Inc.
$649.0K
Michael J. Pellini M.D., MBAChief Executive Officer, President and Director
Foundation Medicine, Inc.
$403.9K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOGENOMICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.